Ten years ago, scientists from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, had developed an experimental vaccine designed to spur production of antibodies against a key malaria parasite protein, AMA1. It showed promise in test-tube and animal experiments and in early-stage clinical trials, but returned disappointing results in recent human trials conducted in malaria-endemic countries. Now, ...
Read MoreYou have just read an article categorized health
titled Research: Vaccine Developed Form Complex of Two Malaria Proteins Protects Mice from Lethal Infection.
Written by:
editor - Tuesday, June 24, 2014
There are currently no comments for "Research: Vaccine Developed Form Complex of Two Malaria Proteins Protects Mice from Lethal Infection"
Post a Comment